Bank of America
PRCT icon

Bank of America’s Procept Biorobotics PRCT Stock Holding History

Bank of America’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
516,198
-114,491
-18% -$2.87M ﹤0.01% 2932
2026
Q1 		$15.8M Buy
630,689
+199,484
+46% +$5.62M ﹤0.01% 2586
2025
Q4 		$13.6M Buy
431,205
+26,959
+7% +$894K ﹤0.01% 2611
2025
Q3 		$14.4M Sell
404,246
-221,439
-35% -$10.1M ﹤0.01% 2927
2025
Q2 		$36M Sell
625,685
-183,838
-23% -$10.4M ﹤0.01% 1983
2025
Q1 		$47.2M Buy
809,523
+186,115
+30% +$12.7M ﹤0.01% 1643
2024
Q4 		$50.2M Buy
623,408
+36,944
+6% +$3.16M ﹤0.01% 1494
2024
Q3 		$47M Sell
586,464
-60,751
-9% -$4.32M ﹤0.01% 1616
2024
Q2 		$39.5M Buy
647,215
+415,599
+179% +$24.7M ﹤0.01% 1627
2024
Q1 		$11.4M Buy
231,616
+146,727
+173% +$6.98M ﹤0.01% 2865
2023
Q4 		$3.56M Buy
84,889
+5,739
+7% +$195K ﹤0.01% 3840
2023
Q3 		$2.6M Buy
79,150
+14,014
+22% +$478K ﹤0.01% 4020
2023
Q2 		$2.3M Sell
65,136
-13,409
-17% -$443K ﹤0.01% 4104
2023
Q1 		$2.23M Sell
78,545
-186,136
-70% -$6.57M ﹤0.01% 4256
2022
Q4 		$11M Sell
264,681
-8,759
-3% -$376K ﹤0.01% 2602
2022
Q3 		$11.3M Buy
273,440
+246,445
+913% +$9.83M ﹤0.01% 2480
2022
Q2 		$882K Buy
26,995
+11,544
+75% +$420K ﹤0.01% 5018
2022
Q1 		$540K Sell
15,451
-3,156
-17% -$75.9K ﹤0.01% 5779
2021
Q4 		$465K Buy
18,607
+18,277
+5,538% +$676K ﹤0.01% 5937
2021
Q3 		$13K Buy
+330
New +$12.7K ﹤0.01% 7505

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America's PRCT Position: Q2 2026 in Review

Bank of America reduced its Procept Biorobotics (PRCT) stake by 18% in Q2 2026, selling an estimated $2.87M and leaving 516,198 shares worth $11.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Bank of America first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $50.2M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Bank of America held 516,198 shares of Procept Biorobotics worth $11.7M as of Q2 2026.
  • Bank of America sold 114,491 Procept Biorobotics shares in Q2 2026, an estimated $2.87M.
  • Procept Biorobotics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2932 holding.
  • Bank of America first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • Bank of America's Procept Biorobotics position peaked at $50.2M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.